Literature DB >> 20039246

Lipophilic pyridinium bisphosphonates: potent gammadelta T cell stimulators.

Yonghui Zhang1, Rong Cao, Fenglin Yin, Fu-Yang Lin, Hong Wang, Kilannin Krysiak, Joo-Hwan No, Dushyant Mukkamala, Kevin Houlihan, Jikun Li, Craig T Morita, Eric Oldfield.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20039246      PMCID： PMC2819003          DOI： 10.1002/anie.200905933

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN： 1433-7851            Impact factor:   15.336


× No keyword cloud information.
  18 in total

1.  Targeting human {gamma}delta} T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer.

Authors:  Francesco Dieli; David Vermijlen; Fabio Fulfaro; Nadia Caccamo; Serena Meraviglia; Giuseppe Cicero; Andrew Roberts; Simona Buccheri; Matilde D'Asaro; Nicola Gebbia; Alfredo Salerno; Matthias Eberl; Adrian C Hayday
Journal:  Cancer Res       Date:  2007-08-01       Impact factor: 12.701

2.  Gammadelta T cells for immune therapy of patients with lymphoid malignancies.

Authors:  Martin Wilhelm; Volker Kunzmann; Susanne Eckstein; Peter Reimer; Florian Weissinger; Thomas Ruediger; Hans-Peter Tony
Journal:  Blood       Date:  2003-03-06       Impact factor: 22.113

3.  Natural and synthetic non-peptide antigens recognized by human gamma delta T cells.

Authors:  Y Tanaka; C T Morita; Y Tanaka; E Nieves; M B Brenner; B R Bloom
Journal:  Nature       Date:  1995-05-11       Impact factor: 49.962

Review 4.  Aminobisphosphonates as new weapons for gammadelta T Cell-based immunotherapy of cancer.

Authors:  Nadia Caccamo; Serena Meraviglia; Giuseppe Cicero; Gaspare Gulotta; Francesco Moschella; Adriana Cordova; Eliana Gulotta; Alfredo Salerno; Francesco Dieli
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

5.  Activity of sulfonium bisphosphonates on tumor cell lines.

Authors:  Yonghui Zhang; Michael P Hudock; Kilannin Krysiak; Rong Cao; Kyle Bergan; Fenglin Yin; Annette Leon; Eric Oldfield
Journal:  J Med Chem       Date:  2007-10-27       Impact factor: 7.446

6.  Bisphosphonates target multiple sites in both cis- and trans-prenyltransferases.

Authors:  Rey-Ting Guo; Rong Cao; Po-Huang Liang; Tzu-Ping Ko; Tao-Hsin Chang; Michael P Hudock; Wen-Yih Jeng; Cammy K-M Chen; Yonghui Zhang; Yongcheng Song; Chih-Jung Kuo; Fenglin Yin; Eric Oldfield; Andrew H-J Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-29       Impact factor: 11.205

7.  Pivaloyloxymethyl-modified isoprenoid bisphosphonates display enhanced inhibition of cellular geranylgeranylation.

Authors:  Andrew J Wiemer; Jose S Yu; Larry W Shull; Rocky J Barney; Brian M Wasko; Kimberly M Lamb; Raymond J Hohl; David F Wiemer
Journal:  Bioorg Med Chem       Date:  2008-02-08       Impact factor: 3.641

Review 8.  Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy.

Authors:  R Graham G Russell; Zhidao Xia; James E Dunford; Udo Oppermann; Aaron Kwaasi; Philippa A Hulley; Kathryn L Kavanagh; James T Triffitt; Mark W Lundy; Roger J Phipps; Bobby L Barnett; Fraser P Coxon; Michael J Rogers; Nelson B Watts; Frank H Ebetino
Journal:  Ann N Y Acad Sci       Date:  2007-11       Impact factor: 5.691

9.  Peripheral blood monocytes are responsible for gammadelta T cell activation induced by zoledronic acid through accumulation of IPP/DMAPP.

Authors:  Anke J Roelofs; Marjo Jauhiainen; Hannu Mönkkönen; Michael J Rogers; Jukka Mönkkönen; Keith Thompson
Journal:  Br J Haematol       Date:  2008-11-07       Impact factor: 6.998

10.  Human T cell receptor gammadelta cells recognize endogenous mevalonate metabolites in tumor cells.

Authors:  Hans-Jürgen Gober; Magdalena Kistowska; Lena Angman; Paul Jenö; Lucia Mori; Gennaro De Libero
Journal:  J Exp Med       Date:  2003-01-20       Impact factor: 14.307
View more
  26 in total

1.  Lipophilic bisphosphonates are potent inhibitors of Plasmodium liver-stage growth.

Authors:  Agam Prasad Singh; Yonghui Zhang; Joo-Hwan No; Roberto Docampo; Victor Nussenzweig; Eric Oldfield
Journal:  Antimicrob Agents Chemother       Date:  2010-05-10       Impact factor: 5.191

2.  Polyoxometalates functionalized by bisphosphonate ligands: synthesis, structural, magnetic, and spectroscopic characterizations and activity on tumor cell lines.

Authors:  Hani El Moll; Wei Zhu; Eric Oldfield; L Marleny Rodriguez-Albelo; Pierre Mialane; Jérôme Marrot; Neus Vila; Israel Martyr Mbomekallé; Eric Rivière; Carole Duboc; Anne Dolbecq
Journal:  Inorg Chem       Date:  2012-06-22       Impact factor: 5.165

3.  Anticancer Activity of Polyoxometalate-Bisphosphonate Complexes: Synthesis, Characterization, In Vitro and In Vivo Results.

Authors:  Amandine Boulmier; Xinxin Feng; Olivier Oms; Pierre Mialane; Eric Rivière; Christopher J Shin; Jiaqi Yao; Tadahiko Kubo; Taisuke Furuta; Eric Oldfield; Anne Dolbecq
Journal:  Inorg Chem       Date:  2017-06-20       Impact factor: 5.165

4.  Critical Roles for Coiled-Coil Dimers of Butyrophilin 3A1 in the Sensing of Prenyl Pyrophosphates by Human Vγ2Vδ2 T Cells.

Authors:  Hong Wang; Mohanad H Nada; Yoshimasa Tanaka; Shun Sakuraba; Craig T Morita
Journal:  J Immunol       Date:  2019-06-21       Impact factor: 5.422

5.  Indirect stimulation of human Vγ2Vδ2 T cells through alterations in isoprenoid metabolism.

Authors:  Hong Wang; Ghanashyam Sarikonda; Kia-Joo Puan; Yoshimasa Tanaka; Ju Feng; José-Luis Giner; Rong Cao; Jukka Mönkkönen; Eric Oldfield; Craig T Morita
Journal:  J Immunol       Date:  2011-10-19       Impact factor: 5.422

Review 6.  Resistance-resistant antibiotics.

Authors:  Eric Oldfield; Xinxin Feng
Journal:  Trends Pharmacol Sci       Date:  2014-11-05       Impact factor: 14.819

7.  Comparison of γδ T cell responses and farnesyl diphosphate synthase inhibition in tumor cells pretreated with zoledronic acid.

Authors:  Atif S M Idrees; Tomoharu Sugie; Chiyomi Inoue; Kaoru Murata-Hirai; Haruki Okamura; Craig T Morita; Nagahiro Minato; Masakazu Toi; Yoshimasa Tanaka
Journal:  Cancer Sci       Date:  2013-03-19       Impact factor: 6.716

8.  Characterization of potential drug targets farnesyl diphosphate synthase and geranylgeranyl diphosphate synthase in Schistosoma mansoni.

Authors:  Peter D Ziniel; Janish Desai; Cynthia L Cass; Craig Gatto; Eric Oldfield; David L Williams
Journal:  Antimicrob Agents Chemother       Date:  2013-09-16       Impact factor: 5.191

9.  Chemo-Immunotherapeutic Anti-Malarials Targeting Isoprenoid Biosynthesis.

Authors:  Yonghui Zhang; Wei Zhu; Yi-Liang Liu; Hong Wang; Ke Wang; Kai Li; Joo Hwan No; Lawrence Ayong; Anmol Gulati; Ran Pang; Lucio Freitas-Junior; Craig T Morita; Eric Old-Field
Journal:  ACS Med Chem Lett       Date:  2013-04-11       Impact factor: 4.345

10.  Structure, Function, and Inhibition of Staphylococcus aureus Heptaprenyl Diphosphate Synthase.

Authors:  Janish Desai; Yi-Liang Liu; Hongli Wei; Weidong Liu; Tzu-Ping Ko; Rey-Ting Guo; Eric Oldfield
Journal:  ChemMedChem       Date:  2016-07-26       Impact factor: 3.466
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.